Osteosarcoma (OS), the most common malignant bone tumor, accounts for the heavy healthy threat in the period of children and adolescents. OS occurrence usually correlates with early metastasis and high death rate. This study aimed to better understand the mechanism of OS metastasis.
Introduction
Osteosarcoma (OS) is the most common primary malignant bone tumor in childhood and adolescence. OS exhibits highly aggressive and early systemic metastasis. [1, 2] About 20% of OS patients appear focus metastasis when they receive the first diagnosis. With the great development of effective chemotherapy combinations, the survival rates of nonmetastatic OS have significantly increased from <20% before 1970s to present rates of 65% to 75%. [3, 4] However, OS systemic metastasis, especially the occurrence of lung metastasis is still the most prominent reason for OS-caused death. Only 11% to 30% of patients suffering from OS metastasis can survive after the combination of surgery resection and chemotherapy. [5, 6] In this way, OS metastasis has become the obstacle for successful OS treatments. OS metastasis is a multistep dynamic progression facilitated by pro-metastasis genes such as myc, [7] ras, [8] and inhibited by metastasis-resistant genes including nm23, [9] p16, [10] kangai1 (KAI-1), [11] KiSS-1 metastasis-suppressor (KISS-1), [12] mitogenactivated protein kinase kinase 4 (MKK4). Although the biological characteristic of OS has been understood a lot, a large scale of regions in molecular mechanisms involved in OS metastasis are still uncovered. Therefore, in order to profoundly improve early diagnostic efficacy and clinical outcomes for patients with OS, it is not only urgent to find out the metastasis mechanism but also to identify molecular that can be used as candidate diagnostic biomarkers or therapeutic targets in OS.
Bioinformatic approaches are increasingly being used in target genes or proteins exploration and analysis. Weighted gene co-expression network analysis (WGCNA) is a novel gene co-expression network-based approach. WGCNA is a systems biology method for molecular interaction mechanism analysis and correlation networks resolving. [13] In accordance with high throughput microarray data, WGCNA can be used to seek synergetic expressed modules and explore the relationship between gene networks and clinical phenotype at transcriptome level. [13] [14] [15] As an effective and accurate bioinformatics method, WGCNA has been widely applied in identifying susceptibility genes, screening candidate targets for disease and cancer fields. [16, 17] In 2017, Liu et al [18] predict gene clusters correlated with the mechanisms of OS using WGCNA, finding that the genes in module 5 are involved in OS. However, the pathogenesis of OS has not been fully revealed.
Previous studies offered a series of Gene Expression Omnibus (GEO) datasets presenting OS related genes expression profile. These analyses comprise bioinformatics data derived from tissue sample of OS patients. In this study, we selected some of these dataset with specific limitation for our bioinformatics analysis. [19] [20] [21] We conducted WGCNA and the following support vector machines (SVM) to analyze OS metastasis related genes and identified key genes potentially participated in OS metastasis progression. With the usage of effective bioinformatic analysis, we can figure out specific key genes that have important clinical implications in disease basic researches and clinical therapy.
Methods

Data collection and preprocessing
Four expression profile data sets of OS metastasis were downloaded from the GEO database (https://www.ncbi.nlm. nih.gov/gds). Datasets GSE14359, GSE21257, GSE32981, and GSE14827 were chosen for further study in accordance with the following rules: datasets belong to OS gene expression profiles; datasets contain OS metastasis and nonmetastasis classification information. GSE14359 dataset was used for OS significantly correlated modules and genes selection, and SVM establishment. The other three datasets were used for independent verification of SVM. Detail information of datasets was shown in Table 1 . GSE14359 and GSE14827 data sets in GEL format were annotated according to the Affymetrix Human Genome U133A and U133 Plus 2.0 Array platforms respectively. The background correction and normalization of these raw data sets were performed by the Affy [22] package in R. GSE32981 was derived from ABI Human Genome Survey Microarray v2.0 platform. GSE21257 was obtained from Illumina [23] human-6 v2.0 expression beadchip (using nuIDs as identifier). GSE32981 and GSE21257 datasets were downloaded in original txt format.
Probes were mapped to gene symbols. Empty probes were discarded according to the annotation platform of each expression profiles. If there were multiple probes that mapped to the same gene symbol, their mean value was considered as the gene expression value. Data were normalized by the limma (linear models for microarray data) package in R.
Screening for differentially expressed genes
The differentially expressed genes (DEGs) between nonmetastasis and metastasis group in GSE14359 were screened by the limma package in R. The adjusted P-value (false discovery rate, FDR) <.05 and jlogFCj > 1 were set as the cut-off criteria.
Screening for OS associated genes and modules by WGCNA
Module identification was accomplished with the dynamic tree cut method. Highly similar modules were identified by cluster analysis and then merged together with a height cut-off of 0.95. For further quantification of OS related genes and modules, the pvalue of gene expression difference between normal group and disease group were evaluated with T-test, and log P was considered as gene significance. The mean value of gene significance (GS) derived from modules comprising gene was defined as module significance.
Establishment of SVM
GSE14539 was set as training dataset. The genes feature combination was obtained through recursive feature elimination (RFE) arithmetic. SVM was established with the selected optimized gene feature combination. To test the stability and transferability of SVM, the generated SVM was verified by using independent test datasets: GSE14827, GSE21257, and GSE32981. The classification effect was determined according to sensitivity (Se), specificity (Sp), positive predictive value (PPV), negative predictive value (NPV), and proportion under Receiver operating characteristic curve (ROC) curve.
Results
Datasets preprocessing and DEGs selection
In order to select OS metastasis associated genes, datasets about OS associated gene expression profiles were downloaded from the GEO Database (see Methods and Fig. 1 for details on the experimental design).
Under the thresholds of jlog FCj > 1 and FDR < 0.05, total 897 DEGs were obtained from GSE14359 dataset. Bidirectional hierarchical clustering was carried out according to the genes expression level and the results were presented by the heat map exhibiting genes mRNA expression level (Fig. 2) .
Dataset network construction and modules detection
In order to identify OS-metastasis associated modules and genes, WGCNA was performed on the obtained 897 DEGs. Firstly, we explored the value of adjacency matrix weighting, power. As shown in Figure 3 , X-axis represents matrix weighting power while the Y-axis represents quadratic correlation index derived Table 1 Datasets of gene expression profiles. Platform  Probe number  Total sample number  Metastasis  Nonmetastasis   GSE32981  GPL3307  14725  23  18  5  GSE21257  GPL10295  48701  53  34  19  GSE14359  GPL96  22283  18  8  10  GSE14827  GPL570  42450  27  9  18 Tian et al. Medicine (2018) 97:24 Medicine The X-axis represents weighting parameters (power). The Y-axis represents quadratic of correlation index from log (k) and log (P(K)). Figure 1 . The workflow of data preparation, processing, analysis, and validation in this study.
GEO accession
Tian com from log (k) and log (P(k)) of the corresponding network. From Figure 3 , we took power as 12 when correlation index reached 0.9 the first time.
In the next step, we calculated community dissimilarity index of DEGs and obtained system clustering tree. According to the standard of dynamic cut tree, we set 30 as the least gene number of each gene network and 0.95 as the cut-height, respectively. After determination of gene modules by using dynamic tree cut method, we computed the eigenvector value of each module. Based on cluster analysis of modules, the closer ones were merged together for new modules' acquisition. Modules partition was shown in Figure 4 , we totally obtained 10 osteosarcomametastasis associated modules.
In further, we qualified the relevance between eigenvalue of network modules and osteosarcoma-metastasis condition (metastasis and nonmetastasis). As shown in Figure 5 , gene significance of each modules were over 0.8 while modules significance P-value was only .0072, far lower than 0.05, indicating significant difference among modules. The specific DEGs in obtained 10 modules were recorded in Table S1 , http:// links.lww.com/MD/C291. The turquoise pattern contained the largest number of DEGs among these modules. So we took DEGs in this module for further study.
Generation and annotation of OS associated module network
We established genes expression network by using OS associated gene expression value from turquoise panel. As shown in Figure 6 , the network contains 231 connection sides and 142 nodes comprising 59 downregulated genes and 83 upregulated genes. All these 142 genes were subjected to Gene Ontology (GO) functional and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses and the annotations were presented in Figure 7 and Table 2 . As shown in Table 2 , nephroblastoma overexpressed (NOV), insulin-like growth factor binding protein 5 (IGFBP5), insulin-like growth factor binding protein 6 (IGFBP6), WNT1 inducible signaling pathway protein 3 (WISP3) and myosin light chain 2 (MYL2) were found in both cell growth regulation and insulin-like growth factor binding groups. These data indicated that these genes and associated functional pathway may contribute to the progression of tumor cell migration.
Optimal characterized genes selection
To confirm typical characterized genes involved in these 142 genes, we chose GSE14359 as training dataset and conducted feature selection with recursive feature elimination (RFE). If there were 12 genes combination, 17 samples were accurately classified with accuracy rate of 94.4% (Fig. 8) . All these 12 genes, especial tumor-associated gene matrix metalloproteinase11 (MMP11), FXYD domain containing ion transport regulator 2 (FXYD2) were presented in Table 3 .
Verification and assessment of SVM
GSE14827, GSE21257, and GSE32981 datasets were utilized to verify the SVM generated by the selected optimized gene feature (Fig. 9) . The analysis results of SVM evaluation index were shown in Table 4 .
Discussion
OS is the most common primary malignant bone tumor, which especially displays highly aggressive and early systemic metastasis in people at young age. [1, 2] More knowledge about the mechanism of OS metastasis is required for OS early diagnosis and treatment. In this study, we identified 897 DEGs. With the usage of WGCNA approach, 142 genes highly related with OS metastasis were obtained. These genes were enriched in cell growth regulation and insulin-like growth factor binding Table 2 Annotation of KEGG pathway enrichment analysis and gene ontology function of differentially expressed genes list. Figure 8 . The optimal characterized genes combination selection by recursive feature elimination. The X-axis presents the number of selected characters. The Y-axis presents prediction accuracy of characters set.
Table 3
The optimal characterized genes combination list. associated GO functions and KEGG pathways. Finally, considered GSE14359 as training dataset and conducted following RFE, we obtained 12 optimal characterized genes including FXYD2 and MMP11. SVM was further verified with the usage of the other 3 GSE14827, GSE21257, and GSE32981 datasets. In this study, the selected 142 DEGs had been classified into several classical pathways ( Table 2 ). Insulin-like growth factor binding proteins (IGFBPs) members can both positively or negatively regulate IGFs function. [24, 25] Among these IGFBPs members, IGFBP6 expression level was increased in OS metastasis group (Fig. 6 ). IGFBP-6 was able to inhibit actions of IGF-II, including IGF-II induced cell proliferation and differentiation by typical IGF-dependent pathway. [26] However, recently studies showed that IGFP6 can also promote cancer cell migration through IGF-independent manner, which may be transduced by mitogen-activated protein kinase (MAPK).
Genes
[27]-WISP3, also named as CCN6, was another increased genes involved in insulin-like growth factor binding. WISP3 was regarded as one potential anti-cancer therapy target because it elicited OS cells metastasis by suppressing activation of TAK1 and p38. [28] To our surprise, IGFBP5, one protein that inhibit tumorigenicity and metastasis of human osteosarcoma, also increased significantly in OS metastasis panel, [29] which indicated the complexity of metastasis process.
In the 12 optimal characterized genes, MMP11 has been detected in many invasive human carcinomas. In oral squamous cell carcinoma, MMP11 expression level was associated with lymph node metastasis. Overexpression of MMP11 in oral squamous cell carcinoma cells also promoted cell migration in vitro. [30] In addition, another report indicated the potential role of MMP11 existing in plasma in disease progression assessment, which suggested MMP11 can be used as biomarker for diagnosis. [31] FXYD domain Containing Ion Transport Regulator 2 (FXYD2) was the modulating subunit of Na+/K+-ATPases. In OCCC tissues, FXYD2 significantly expressed. Deficiency of FXYD2 led to tumor growth suppression, which indicated that FXYD2 had the possibility to be antitumor target. [32] Although we identified DEGs between OS metastasis and nonmetastasis through bioinformatics methods, we did not conduct experimental test for any of these selected genes, which was a limitation of this study. Functional analysis is necessary to further study the functions of these genes in OS metastasis progress regulation.
In conclusion, IGFBP5, IGFBP6, WISP3, and MYL2 were involved in Insulin-like growth factor binding. This correlation gave us hypothesis that insulin-like growth factor binding associated genes may play important role in deciding OS metastasis progression. More basic functional experiments need to be conducted to investigate these involved genes function to explore more anti-tumor and metastasis inhibition targets. 
